Ask AI
ProCE Banner Activity

HIV Update Webinar 2 : CCO Official Conference Coverage of IAS 2025

Video

Stream this on-demand webinar to review new advancements in HIV prevention and treatment from the IAS 2025 conference, with commentary and insights from our expert faculty. 

Released: July 31, 2025

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society

 
ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

IAS

ProCE Banner

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection. 

Program Learning Goal

The goal of this activity is to improve the knowledge and competence of learners in applying new findings to optimize treatment and prevention strategies for HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Disclosure

Primary Author

Daniel R. Kuritzkes, MD: consultant/advisor/speaker: AbbVie, Gilead, GlaxoSmithKline, Janssen, Merck, ViiV; researcher: Merck, ViiV; other financial or material support: Gilead, Janssen.

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GlaxoSmithKline, Merck Sharp & Dohme, ViiV.